2017年第二版NCCN甲状腺肿瘤指南解读 |
| |
引用本文: | 郑向前,候秀坤,高明. 2017年第二版NCCN甲状腺肿瘤指南解读[J]. 中国肿瘤临床, 2018, 45(1): 14-17. DOI: 10.3969/j.issn.1000-8179.2018.01.046 |
| |
作者姓名: | 郑向前 候秀坤 高明 |
| |
作者单位: | 天津医科大学肿瘤医院甲状腺颈部肿瘤科,国家肿瘤临床医学研究中心,天津市肿瘤防治重点实验室,天津市恶性肿瘤临床医学研究 中心(天津市300060) |
| |
摘 要: | 甲状腺肿瘤是内分泌系统最常见的恶性肿瘤。随着各学科基础研究与技术方法的不断发展,甲状腺肿瘤的临床诊断与治疗以及对甲状腺癌的认识也在不断地进步。在最新版美国国立综合癌症网(NCCN)指南中,甲状腺结节的术前评估、手术方式及范围、术后促甲状腺激素(TSH)抑制治疗等方面均有所改变,可为国内甲状腺结节的诊断与治疗提供借鉴。
|
关 键 词: | 美国国立综合癌症网 甲状腺肿瘤 诊治指南 |
收稿时间: | 2017-09-15 |
Interpretation of the second edition of the NCCN guidelines for thyroid cancer in 2017 |
| |
Affiliation: | Department of Thyroid and Neck Tumor, Tianjin Medical University Cancer Institute and Hospital; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center for Cancer; National Clinical Research Center of Cancer, Tianjin 300060, China |
| |
Abstract: | Thyroid carcinoma is the most common cancer that affects the endocrine system. With the development of research methods and techniques of various disciplines, the clinical diagnosis, treatment, and understanding of thyroid carcinoma are constantly progressing. In the latest edition of the National Comprehensive Cancer Network (NCCN) guidelines, the preoperative evaluation of thyroid nodules, the mode and range of the operation, and the treatment involving postoperative thyroid stimulating hormone (TSH) suppression have changed, all of which can provide a reference for the diagnosis and treatment of thyroid nodules. |
| |
Keywords: | |
|
| 点击此处可从《中国肿瘤临床》浏览原始摘要信息 |
|
点击此处可从《中国肿瘤临床》下载免费的PDF全文 |
|